Actively Recruiting
National Registry of IgG4-RD in China
Led by Peking Union Medical College Hospital · Updated on 2017-01-24
900
Participants Needed
1
Research Sites
521 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of this study is to establish a nation-wide cohort study of IgG4-related disease (IgG4-RD) in China. Methods: All the patients fulfilling diagnostic criteria of IgG4-RD (2011) would be enrolled from multi-centers around China. A online database system has been established. Endpoints: The primary endpoint is to investigate the clinical manifestations of Chinese IgG4-RD patients; the secondary endpoints including the demographic features,laboratory characteristics, immunological tests, imaging and pathological features, in addition, the treatment and prognosis of the disease.
CONDITIONS
Official Title
National Registry of IgG4-RD in China
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Conforming to the diagnostic criteria of IgG4-RD (2011)
You will not qualify if you...
- Excluding other mimicking IgG4-RD, including tumors, vasculitis and sarcoidosis.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Peking Union Medical College Hospital
Beijing, Beijing Municipality, China, 100032
Actively Recruiting
Research Team
Y
Yunyun Fei
CONTACT
W
Wen Zhang
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here